9FM5 | pdb_00009fm5

PvSub1 Catalytic Domain in Complex with Peptidomimetic Inhibitor (AL-97)


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.60 Å
  • R-Value Free: 
    0.224 (Depositor), 0.214 (DCC) 
  • R-Value Work: 
    0.196 (Depositor), 0.188 (DCC) 
  • R-Value Observed: 
    0.197 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 9FM5

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history

Literature

Towards Improved Peptidic alpha-Ketoamide Inhibitors of the Plasmodial Subtilisin-Like SUB1: Exploration of N-Terminal Extensions and Cyclic Constraints.

Puszko, A.K.Batista, F.A.Ejjoummany, A.Bouillon, A.Maurel, M.Adler, P.Legru, A.Martinez, M.Ortega Varga, L.Hadjadj, M.Alzari, P.M.Blondel, A.Haouz, A.Barale, J.C.Hernandez, J.F.

(2025) ChemMedChem 20: e202400924-e202400924

  • DOI: https://doi.org/10.1002/cmdc.202400924
  • Primary Citation Related Structures: 
    9FM5

  • PubMed Abstract: 

    After more than 15 years of decline, the Malaria epidemy has increased again since 2017, reinforcing the need to identify drug candidates active on new targets involved in at least two biological stages of the Plasmodium life cycle. The SUB1 protease, which is essential for parasite egress in both hepatic and blood stages, would meet these criteria. We previously reported the structure-activity relationship analysis of α-ketoamide-containing inhibitors encompassing positions P4-P2'. Despite compounds with high inhibitory potencies were identified, their antiparasitic activity remained limited, probably due to insufficient cell permeability. Here, we present our efforts to improve it through the N-terminal introduction of basic or hydrophobic moieties and/or cyclization. Compared to our previous reference compounds 1/2 (Ac-Ile/Cpg-Thr-Ala-AlaCO-Asp-Glu(Oall)-NH2), we identified analogues with improved Pf-/PvSUB1 inhibition (IC50 values in the 10-20 nM  range) and parasite growth inhibition (up to 98% at 100 μM). The increase in potency was mainly observed when increasing the overall hydrophobicity of the compounds. Conjugation to the cell penetrating peptide octa-arginine was also favorable. Finally, the crystal structure of PvSUB1 in complex with compound 15 has been determined at 1.6 Å resolution. Compared to compound 1, this structure extended to the P5 residue and revealed two additional hydrogen bonds.


  • Organizational Affiliation
    • Université de Montpellier: Universite de Montpellier, IBMM, Montpellier, FRANCE.

Macromolecule Content 

  • Total Structure Weight: 142.46 kDa 
  • Atom Count: 5,917 
  • Modeled Residue Count: 697 
  • Deposited Residue Count: 1,278 
  • Unique protein chains: 2

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
subtilisin
A, B
631Plasmodium vivaxMutation(s): 3 
Gene Names: sub1PVC01_100035100PVT01_100029100PVW1_100050600
EC: 3.4.21.62
UniProt
Find proteins for A5KB03 (Plasmodium vivax (strain Salvador I))
Explore A5KB03 
Go to UniProtKB:  A5KB03
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupA5KB03
Glycosylation
Glycosylation Sites: 1
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:  Sequence   |   3D Structure  
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
5,6-DIHYDRO-BENZO[H]CINNOLIN-3-YLAMINEC [auth D],
D [auth E]
8synthetic constructMutation(s): 0 

Small Molecules

Ligands 3 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
NAG

Query on NAG



Download:Ideal Coordinates CCD File
H [auth A],
M [auth B]
2-acetamido-2-deoxy-beta-D-glucopyranose
C8 H15 N O6
OVRNDRQMDRJTHS-FMDGEEDCSA-N
SO4

Query on SO4



Download:Ideal Coordinates CCD File
I [auth A],
N [auth B],
O [auth B]
SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
CA

Query on CA



Download:Ideal Coordinates CCD File
E [auth A]
F [auth A]
G [auth A]
J [auth B]
K [auth B]
E [auth A],
F [auth A],
G [auth A],
J [auth B],
K [auth B],
L [auth B]
CALCIUM ION
Ca
BHPQYMZQTOCNFJ-UHFFFAOYSA-N
Modified Residues  1 Unique
IDChains TypeFormula2D DiagramParent
2KY
Query on 2KY
C [auth D],
D [auth E]
L-PEPTIDE LINKINGC7 H13 N O2

--

GMA
Query on GMA
C [auth D],
D [auth E]
L-PEPTIDE LINKINGC5 H10 N2 O3GLU
VEF
Query on VEF
C [auth D],
D [auth E]
L-PEPTIDE LINKINGC4 H9 N O4

--

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.60 Å
  • R-Value Free:  0.224 (Depositor), 0.214 (DCC) 
  • R-Value Work:  0.196 (Depositor), 0.188 (DCC) 
  • R-Value Observed: 0.197 (Depositor) 
Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 53.201α = 90
b = 106.067β = 90.51
c = 72.159γ = 90
Software Package:
Software NamePurpose
BUSTERrefinement
XDSdata reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Agence Nationale de la Recherche (ANR)FranceANR-19-CE18-0010-01

Revision History  (Full details and data files)

  • Version 1.0: 2025-02-05
    Type: Initial release
  • Version 1.1: 2025-04-30
    Changes: Database references